Evaluating Published Skin Dose Tolerance Limits for Stereotactic Body Radiation Therapy of Lung Cancer
نویسندگان
چکیده
منابع مشابه
Evaluating Published Skin Dose Tolerance Limits for Stereotactic Body Radiation Therapy of Lung Cancer
Objectives: Published local control rates for certain stereotactic body radiotherapy (SBRT) lung cancer treatments have exceeded 97%, but several serious adverse events have been reported. No five-year normal tissue complication probability (NTCP) statistical analysis SBRT results have been published yet for skin. While we expectantly await these publications, the goal of this manuscript is to ...
متن کاملDose Tolerance for Stereotactic Body Radiation Therapy.
Normal tissue complication probability (NTCP) results were detailed in the July 2001 issue of Seminars in Radiation Oncology for conventionally fractionated radiation therapy. After 7 years, an extensive collection of stereotactic ablative body radiotherapy (SABR) or stereotactic body radiation therapy (SBRT) dose-tolerance limits was presented in the October 2008 issue of Seminars in Radiation...
متن کاملEstimated Risk Level of Unified Stereotactic Body Radiation Therapy Dose Tolerance Limits for Spinal Cord.
A literature review of more than 200 stereotactic body radiation therapy spine articles from the past 20 years found only a single article that provided dose-volume data and outcomes for each spinal cord of a clinical dataset: the Gibbs 2007 article (Gibbs et al, 2007(1)), which essentially contains the first 100 stereotactic body radiation therapy (SBRT) spine treatments from Stanford Universi...
متن کاملStereotactic body radiation therapy (SBRT) for lung cancer
Stereotactic body radiation therapy (SBRT) has evolved over the past 15 years and revolutionized the management of early stage non-small cell lung cancer (NSCLC). Compared to conventional radiation therapy, SBRT offers superior outcomes, lower costs and greater patient convenience.1 SBRT likewise offers local control and cancer outcomes approaching surgical resection2-8 with lower risk of treat...
متن کاملStereotactic body radiation therapy for inoperable early stage lung cancer.
CONTEXT Patients with early stage but medically inoperable lung cancer have a poor rate of primary tumor control (30%-40%) and a high rate of mortality (3-year survival, 20%-35%) with current management. OBJECTIVE To evaluate the toxicity and efficacy of stereotactic body radiation therapy in a high-risk population of patients with early stage but medically inoperable lung cancer. DESIGN, S...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cureus
سال: 2012
ISSN: 2168-8184
DOI: 10.7759/cureus.51